30. 04.2018

genae appoints new board member

Category: News

Today, genae announced the appointment of Ingrid Maes as a member of its board of directors.

Ingrid gained a Master in Engineering Sciences - Chemistry & Biotechnology, Medicinal chemistry from the University of Brussels. She is co-Founder and Managing Director of Inovigate. Ingrid has more than 30 years of experience in the pharmaceutical, medical device and the life science sector, and 15 years of experience in international leadership roles at Alfa Laval, Siemens and PwC.

She is an expert in business planning and strategy formulation, in R&D and market access, manufacturing and regulatory compliance and bridges the scientific / technology world with the strategy and finance aspects of the business.

Ingrid brings a wealth of expertise to the board of genae and her appointment coincides with the company’s continuing efforts and investments in providing groundbreaking services to the health management industry.